Renal function and safety of heart transplant recipients switched to mycophenolate mofetil and low-dose cyclosporine

By Baryalei M.   Zenker D.   Pieske B.   Tondo K.   Dalichau H.   Aleksic I.  

Transplantation Proceedings, Vol. 35, Iss. 4, 2003-06 ,pp. : 1539-1542

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of low-dose ketoconazole (50 mg) to reduce the cost of cyclosporine in renal allograft recipients

By Abraham M.A.   Thomas P.P.   John G.T.   Job V.   Shankar V.   Jacob C.K.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 215-216

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of Losartan in renal transplant recipients

By Hadjigavriel M.   Kyriakides G.  

Transplantation Proceedings, Vol. 31, Iss. 8, 1999-12 ,pp. : 3300-3301

Elsevier

Access to resources Recommend Favorite

Safety and efficacy of delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors over 55 years of age

By Gentil M.A.   Osuna A.   Capdevila L.   Rodriguez-Algarra G.   Cantarell C.   Pereira P.   Gonzalez-Molina M.   Spanish Kidney Transplant of Elderly Donor Study Group  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1706-1708

Elsevier

Access to resources Recommend Favorite

Basiliximab-sirolimus-prednisone induction regimen followed by delayed low-dose cyclosporine in renal transplant recipients of living donors

By Langer R.M.   Hong D.M.   Katz S.M.   Van Buren C.T.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3162-3164

Elsevier

Access to resources Recommend Favorite